SII partners with Univercells for affordable personalised oncology
Univercells and SII believe that they may be able to dramatically accelerate the progress of new medicines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
immunotherapies
PDC*line Pharma, partners get €8.1mn from Walloon region, BioWin for personalised therapeutic…
Collaborative effort between biotech companies, PDC*line Pharma and OncoDNA, technology company salamanderU and universities…
Vaccitech begins Phase 1 clinical study of VTP-300 immunotherapeutic to treat chronic Hepatitis B
Once the VTP-300 prime dose is confirmed, Vaccitech plans to initiate a Phase 1b/2a study, HBV002, in Q3 2020
Scientists identify targets for COVID-19 vaccine
The researchers looked for regions that would stimulate a memory T-cell response that, when paired with the right B cells, would…